KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Capital Leases: 2020-2022

Historic Capital Leases for Ginkgo Bioworks Holdings (DNA) over the last 1 years, with Sep 2022 value amounting to $59.8 million.

  • Ginkgo Bioworks Holdings' Capital Leases rose 267.85% to $59.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $59.8 million, marking a year-over-year increase of 267.85%. This contributed to the annual value of $22.3 million for FY2021, which is 34.90% up from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Capital Leases stood at $59.8 million for Q3 2022, which was up 16.10% from $51.5 million recorded in Q2 2022.
  • Ginkgo Bioworks Holdings' 5-year Capital Leases high stood at $59.8 million for Q3 2022, and its period low was $16.3 million during Q3 2021.
  • For the 3-year period, Ginkgo Bioworks Holdings' Capital Leases averaged around $32.3 million, with its median value being $24.8 million (2021).
  • Data for Ginkgo Bioworks Holdings' Capital Leases shows a peak YoY surged of 267.85% (in 2022) over the last 5 years.
  • Quarterly analysis of 3 years shows Ginkgo Bioworks Holdings' Capital Leases stood at $16.5 million in 2020, then skyrocketed by 34.90% to $22.3 million in 2021, then skyrocketed by 267.85% to $59.8 million in 2022.
  • Its Capital Leases was $59.8 million in Q3 2022, compared to $51.5 million in Q2 2022 and $27.3 million in Q1 2022.